Cushing's disease — hyperadrenocorticism — is one of the most common endocrine disorders in middle-aged and senior dogs, and one of the most supplementation-complicated. The excess cortisol that defines the condition simultaneously suppresses immune function, degrades skin integrity, induces muscle wasting, damages the hepatic parenchyma, and alters gut microbiome composition. That multi-system disruption creates real opportunities for targeted nutritional support — but it also creates specific contraindications that are important to understand before adding anything to the regimen of a Cushing's dog.

What Cushing's disease actually is

Hyperadrenocorticism results from chronic excess cortisol production. In approximately 80–85% of cases, the cause is a pituitary adenoma (pituitary-dependent hyperadrenocorticism, PDH) that produces excess ACTH, which chronically stimulates both adrenal glands to overproduce cortisol. In 15–20% of cases, a functional adrenal tumor (adrenal-dependent hyperadrenocorticism, ADH) autonomously secretes cortisol independently of pituitary regulation. Iatrogenic Cushing's — caused by chronic glucocorticoid administration — is a third category that clinically resembles the endogenous forms.

The clinical presentation is recognizable: polyuria, polydipsia, polyphagia, pendulous abdomen, truncal muscle wasting with limb muscle preservation, alopecia in a bilaterally symmetric pattern, thin and easily bruised skin, comedones, and recurrent infections. ACTH stimulation and low-dose dexamethasone suppression tests distinguish PDH from ADH; abdominal ultrasound and pituitary imaging (MRI) complete the workup.

Trilostane and mitotane are the primary veterinary treatments for PDH and ADH respectively. Supplements are adjuncts only — they do not treat the underlying cortisol excess, and the treating veterinarian must be involved in any supplementation decision.

What hypercortisolemia does to the body — and where supplements fit

Cortisol excess produces a coherent pattern of multi-system breakdown that creates specific supplementation targets:

Skin and coat: Chronic elevated cortisol thins the dermis, impairs keratinocyte proliferation, reduces collagen synthesis, and degrades the epidermal barrier. The result is the characteristic Cushingoid skin: thin, inelastic, prone to comedones, calcinosis cutis, and secondary bacterial and yeast infections. Omega-3 EPA+DHA partially restores barrier lipid composition; biotin supports keratinocyte function; zinc supports wound healing and keratinocyte integrity. These don't reverse Cushingoid skin changes while cortisol is elevated, but they reduce secondary severity.

Hepatic involvement: Cortisol excess causes steroid hepatopathy — vacuolar hepatocellular change with glycogen accumulation — in the majority of Cushing's dogs. Liver enzymes (particularly ALP) are markedly elevated in most cases as a direct cortisol effect. SAMe (S-adenosylmethionine) is a hepatoprotectant with documented efficacy in canine hepatic disease; it supports glutathione synthesis and methylation reactions in damaged hepatocytes. Milk thistle (silymarin) has antioxidant and mild anti-fibrotic effects in hepatic tissue. Both are routinely used as hepatic adjuncts in Cushing's dogs by veterinary internists, particularly when ALP elevation is marked or when concurrent hepatic disease is present.

Gut microbiome: Chronic glucocorticoid excess alters gut motility, increases intestinal permeability, and disrupts microbiome composition toward dysbiosis. Cushing's dogs are simultaneously immunosuppressed and gut-dysbiotic — a combination that increases infection risk and reduces immune resilience. Probiotics with documented canine-strain evidence (Lactobacillus acidophilus, Enterococcus faecium) support microbiome restoration and are low-risk in this context.

Muscle wasting: Cortisol drives protein catabolism in skeletal muscle (while sparing fat deposition). Cushing's dogs lose appendicular muscle mass and develop the pendulous abdomen of visceral fat redistribution. Adequate high-quality dietary protein helps offset catabolism; L-carnitine supports mitochondrial fat metabolism and muscle energy production. These are supportive, not restorative of lost muscle while cortisol remains elevated.

What to avoid in Cushing's dogs

Immune stimulants: Cushing's dogs are immunosuppressed by cortisol excess — infections (particularly skin, urinary tract, and respiratory) are more common and more severe. Immune-stimulating supplements (echinacea, medicinal mushroom beta-glucan products, certain herbal adaptogens marketed as immune boosters) are poorly characterized in the context of endocrine immunosuppression and should be avoided without specific veterinary guidance. The immunosuppression in Cushing's is hormonally driven — layering immune stimulants onto a disrupted immune axis is unpredictable.

Supplements affecting cortisol or adrenal function: Several herbal supplements are described as "adrenal support" or "cortisol modulating" in human health marketing — including ashwagandha, rhodiola, and licorice root. These have no established veterinary evidence base and have theoretical potential to interfere with cortisol dynamics in ways that complicate endocrine management. Avoid them in Cushing's dogs.

High-dose antioxidants during active disease: The evidence base here is less definitive, but high-dose vitamin C supplementation has limited rationale in dogs (who synthesize ascorbate endogenously) and excessive antioxidant supplementation in the context of active hormonal disease is not supported. Moderate-dose vitamin E as a synergistic partner to omega-3 is appropriate; megadose antioxidant stacks are not.

The Cushing's supplement protocol

• Omega-3 EPA+DHA — for skin barrier support, anti-inflammatory modulation, and immune calibration. Use at standard therapeutic doses (not the maximum anti-platelet doses); safe as an adjunct to trilostane or mitotane
• SAMe (S-adenosylmethionine) — 200–400 mg/day depending on bodyweight; hepatoprotective adjunct, widely used by veterinary internists in Cushing's dogs with hepatopathy
• Milk thistle (silymarin) — 70–200 mg/day; synergistic with SAMe for hepatic antioxidant support
• Probiotics — for gut-immune calibration; low-risk and broadly relevant given the dysbiosis and immunosuppression dynamic
• Biotin + zinc — for skin integrity support; reduces secondary severity of Cushingoid dermatopathy
• All supplementation coordinated with the treating veterinarian — Cushing's is actively managed; medication interactions and disease monitoring affect what is appropriate at each stage

Related: liver supplement guide · skin supplement guide · probiotics for dogs · hypothyroidism supplement guide · senior dog supplement guide.